MarginsXMarginsX
Home › Markets › Health Care › TPST

Tempest Therapeutics Inc. (TPST)

TPST trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3418
-10.50% on the day
Market cap
$6.8M
Nano cap
Revenue
No annual revenue filed since the period ending 2017-12-31
Net income
No annual revenue filed since the period ending 2017-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTPST on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001544227

Financials

No annual revenue filed since the period ending 2017-12-31.

Warning signs

Cash runway
0.5 months
$779K cash at June 30, 2026
Share count, 1 year
+350.3%
2025-10-30 to 2026-11-13 · +1250.5% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$500K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Accordingly, there is substantial doubt about the Company's ability to continue to operate as a going concern for a period of 12 months from the date of issuance of these condensed consolidated financial statements."
10-Q 2026-11-13
Cash and burn$779K cash; operating cash flow -$5.2M a quarter.Report 2026-06-30
Shares outstanding19,995,358 (2026-11-13); 4,440,161 a year earlier; 19,247,495 three years earlier. 3y figure adjusted for splits (1-for-13 overall).Cover page 2026-11-13
Reverse splits, 3 years1; latest 1-for-13 on 2025-04-09Source 2025-04-09
Shelf and offerings, 12 months4 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-11-25
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-11-06
AuditorErnst & Young LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-04-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $500K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$5.2M-$2.8M$779K$0Needs four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$27.7M-$7.6M$1.8MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$4.0M-$3.6M$7.7M$0Needs four quarters10-K 2026-03-30
Q3 2025
2025-09-30
Not filed-$3.5M-$6.8M$7.5M$0Needs four quarters10-Q 2025-11-05
Q2 2025
2025-06-30
Not filed-$7.9M-$8.4M$14.3M$0Needs four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$10.9M-$8.0M$21.5M$4.2MNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$13.8M-$10.1M$30.3M$6.4MNeeds four quarters10-K 2026-03-30
Q3 2024
2024-09-30
Not filed-$10.6M-$10.2M$22.1M$8.5MNeeds four quarters10-Q 2025-11-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week+0.3%
1 month-43.9%
3 months-67.4%
Year to date-86.7%
1 year-95.7%
From 52-week high-95.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SNGXSoligenix Inc.$0.2882-10.22%$6.7M
TCRTAlaunos Therapeutics Inc.$1.60-1.84%$6.7M
XCURExicure Inc.$1.07-0.93%$7.0M
ADXNAddex Therapeutics Ltd$3.83-5.67%$6.5M
LGVNLongeveron Inc.$2.14-14.06%$7.2M
ENVBEnveric Biosciences Inc.$1.44-4.95%$6.4M
IMRNImmuron Limited$0.8996+2.23%$7.3M
CURXCuranex Pharmaceuticals Inc$4.63-0.11%$7.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier